Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

Surrogate endpoints in HTA: Reflections on my HTAi panel discussion

Press Releases | July 2, 2024 | Petauri Evidence

Calum Jones (Associate Director – Health Economics, Mtech Access) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health...

US and European Market Access for Medical Devices – Free Guide

White Papers and Resources | July 2, 2024 | Petauri Evidence

We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available. Our...

Say Goodbye to Costly Delays – Origins’ Clinical Trial Participant Simulations Have the Answer!

Press Releases | July 2, 2024 | Origins – The Patient Focused Specialists

Lack of Patient Involvement in Clinical Trial Designs Causes Major Issues Low recruitment and retention of clinical trials is a key issue faced by many clinical trials. These can lead...

Joint Clinical Assessments: bureaucratic nightmare, AI opportunity, or both?

White Papers and Resources | June 28, 2024 | Amiculum

By Manca Povsic and Andrew Dobb

Unrivalled Convenience – Perks of Virtual Medical Education

Videos and Podcasts | June 27, 2024 | Impetus Digital

Explore the unrivalled convenience of virtual collaboration in medical education with our new series, "Perks of Virtual Medical Education." Learn why this flexible, efficient mode of learning is the future...

OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

Press Releases | June 24, 2024 | OPEN Health

OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine...

Eyes on the horizon: six (and a half) predictions for the future of healthcare communications

White Papers and Resources | June 21, 2024 | Amiculum

By Zoë van Helmond and Leyna Prince

Unleashing Creativity in Virtual Pharma Engagements

Videos and Podcasts | June 20, 2024 | Impetus Digital

Think outside the box with virtual engagements! Discover how creative asynchronous touchpoints can revolutionize your interactions. Explore everything from OLAs to treatment pathway profiling via a pharma-compliant virtual platform.

Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program

Press Releases | June 18, 2024 | Genesis Research Group

Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life...

Alice Beer of ITN Business recently interviewed David W. Miller, CEO of Genesis Research Group, on ‘Advancing Healthcare’

Videos and Podcasts | June 18, 2024 | Genesis Research Group

ITN Business invited Genesis Research Group to contribute to a news style programme 'Advancing Healthcare' featuring key opinion leaders in the healthcare sector. Our CEO David W. Miller was one...